ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0012

A Novel Mechanism Linking Mucosal Bacteria with Autoantibody Responses in RA: Acetylated Bacterial Lysate as a Model Antigen

Mikhail Volkov, Arieke Kampstra, Karin van Schie, Joanneke Kwekkeboom, Tom WJ Huizinga, René Toes and Diane van der Woude, Leiden University Medical Center, Leiden, Netherlands

Meeting: ACR Convergence 2021

Keywords: Anti-citrullinated Protein Autoantibodies (ACPAs), Autoantibody(ies), microbiome, Mouse Models, RA, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Title: RA – Etiology & Pathogenesis Poster (0011–0045)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Rheumatoid arthritis (RA) is characterized by autoantibodies against post-translationally modified proteins (AMPA) such as citrullinated, carbamylated and acetylated proteins. Importantly, these antibodies are highly multireactive, as they often recognize more than one of these post-translational modifications. Despite extensive research, the antigens inducing the breach of tolerance remain unknown, although microbial antigens are often suspected. Various bacteria are known to be capable of acetylation, therefore, it is intriguing to know which mechanisms underlie the breach of tolerance towards acetylated proteins and development of AMPA. The aim of this project was to investigate whether acetylated proteins of bacterial origin (1) are recognized by human derived AMPA and AMPA-expressing B cells; and (2) can induce AMPA development when used to immunize mice.

Methods: Acetylated E. coli proteins were acquired with two separate methods (Figure A): by culturing E. coli in a condition promoting auto-acetylation (intrinsically acetylated bacterial proteins, IABP), or by directly acetylating lysate-derived proteins via a chemical reaction (extrinsically acetylated BP, EABP). Acetylated ovalbumin (AcOVA) served as positive control for AMPA induction in mice, while non-acetylated BP (NABP) and phosphate buffer saline (PBS) served as negative control. Mice were immunized with these proteins and the resulting antibody response was studied by ELISA. Furthermore, EABP/IABP/NABP were investigated for recognition by human-derived AMPA with ELISA and AMPA-expressing B cells with spleen tyrosine kinase (Syk) phosphorylation assay; acetylated human fibrinogen and native fibrinogen served as positive and negative control.

Results: Intrinsic acetylation resulted in partial, while extrinsic/chemical acetylation resulted in complete acetylation of E. coli proteins. Repetitive immunization of mice with EABP resulted in an AMPA response recognizing acetylated, carbamylated and citrullinated proteins, which was not observed in mice immunized with NABP or IABP (Figure B). Human-derived AMPA recognized EABP and IABP (Figure C). B cell activation (measured by Syk phosphorylation) assay indicated that AMPA-expressing B cells recognized EABP and (to a lesser extent) IABP, but not NABP (Figure D).

Conclusion: Acetylated bacterial proteins are potent antigens that can induce cross-reactive AMPA responses in mice, and can be recognized by human AMPA and AMPA-expressing B cells. This suggests that acetylated bacterial proteins could potentially be involved in the breach of tolerance in RA.

A: Methods of E. coli proteins acetylation. B: AMPA reactivities in mice immunized with extrinsically (chemically) acetylated bacterial proteins and control antigens. Delta OD values measured with titrated mice serum on modified fibrinogen ELISA are depicted. C: Recognition of bacterial protein samples by AMPA derived from RA patients. Delta OD obtained with cross-linking ELISA are depicted. D: Activation of AMPA IgG expressing B cells as measured by Syk phosphorylation assay using flow cytometry. Histograms visualizing mean fluorescence intensity values of stimulated cells stimulated with different bacterial protein samples are depicted.


Disclosures: M. Volkov, None; A. Kampstra, None; K. van Schie, None; J. Kwekkeboom, None; T. Huizinga, None; R. Toes, None; D. van der Woude, None.

To cite this abstract in AMA style:

Volkov M, Kampstra A, van Schie K, Kwekkeboom J, Huizinga T, Toes R, van der Woude D. A Novel Mechanism Linking Mucosal Bacteria with Autoantibody Responses in RA: Acetylated Bacterial Lysate as a Model Antigen [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-novel-mechanism-linking-mucosal-bacteria-with-autoantibody-responses-in-ra-acetylated-bacterial-lysate-as-a-model-antigen/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-mechanism-linking-mucosal-bacteria-with-autoantibody-responses-in-ra-acetylated-bacterial-lysate-as-a-model-antigen/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology